Poddubnyy Denis, Kiltz Uta, Danve Abhijeet, Wright Grace, Haberman Rebecca, Biljan Ana, Clewell Jerry, Urbanik Jamie, Jones Heather, Magrey Marina
Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Canada.
Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Rheumatol Adv Pract. 2025 May 26;9(3):rkaf063. doi: 10.1093/rap/rkaf063. eCollection 2025.
To assess the psychosocial impact of axial spondyloarthritis (axSpA).
A literature search was conducted in two stages: stage 1 included all patients with axSpA and stage 2 focused on patients with inadequate response to prior TNF inhibitor treatment. Selection criteria included population (adults with axSpA), outcomes of interest (psychosocial factors potentially impacted by axSpA, e.g. quality of life, mental health and work productivity) and context [disease-related (disease activity, pain) and -unrelated (gender, race, ethnicity, behaviour) factors potentially affecting psychosocial outcomes). Search results were categorized based on the core domains of disease activity, pain, morning stiffness, fatigue, physical function and overall functioning and health in patients with axSpA.
A total of 197 articles were included in this review, most of which were observational, with only one randomized controlled trial (RCT). The evidence suggests an association between greater disease burden and poorer psychosocial outcomes as well as a bidirectional relationship between disease components and psychosocial outcomes, both contributing to the overall disease burden. However, while many studies reported on psychosocial outcomes, potential relationships with disease domains or activity were not evaluated. Furthermore, there were inconsistencies across studies in how these outcomes were measured, such as the use of different tools and/or scales.
Given the paucity of RCTs examining psychosocial outcomes in axSpA, future research should focus on standardizing assessment of psychosocial impairments experienced by patients and establishing appropriate interventions and management strategies to ensure the holistic treatment of patients with axSpA and to optimize treatment response and outcomes.
评估轴性脊柱关节炎(axSpA)的社会心理影响。
文献检索分两个阶段进行:第一阶段纳入所有axSpA患者,第二阶段聚焦于对先前肿瘤坏死因子抑制剂治疗反应不佳的患者。选择标准包括人群(成年axSpA患者)、感兴趣的结局(可能受axSpA影响的社会心理因素,如生活质量、心理健康和工作效率)以及背景[可能影响社会心理结局的疾病相关(疾病活动度、疼痛)和非疾病相关(性别、种族、民族、行为)因素]。检索结果根据axSpA患者疾病活动度、疼痛、晨僵、疲劳、身体功能以及整体功能和健康的核心领域进行分类。
本综述共纳入197篇文章,其中大部分为观察性研究,仅有一项随机对照试验(RCT)。证据表明,更高的疾病负担与更差的社会心理结局之间存在关联,以及疾病组成部分与社会心理结局之间存在双向关系,二者均导致整体疾病负担。然而,虽然许多研究报告了社会心理结局,但未评估其与疾病领域或活动的潜在关系。此外,各研究在这些结局的测量方式上存在不一致,例如使用不同的工具和/或量表。
鉴于检验axSpA社会心理结局的RCT较少,未来研究应专注于标准化评估患者经历的社会心理损害,并制定适当的干预措施和管理策略,以确保对axSpA患者进行整体治疗,并优化治疗反应和结局。